The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy
Abstract
BACKGROUND.: Previous studies have shown cognitive impairment in breast cancer survivors who were exposed to adjuvant chemotherapy. Neural damage by chemotherapy might have played some part in these findings. The current study explored the regional brain volume difference between breast cancer survivors exposed to adjuvant chemotherapy (C+) and those unexposed (C−). METHODS.: High‐resolution 1.5‐tesla brain magnetic resonance imaging (MRI) databases of breast cancer survivors and healthy controls were used. Brain images were preprocessed for optimal voxel‐based morphometry. Comparisons of gray matter and white matter were performed between the C+ and the C− groups, by using MRI scans from within 1 year (the 1‐year study, n = 51 and n = 55, respectively) or 3 years after their cancer surgery (the 3‐year study, n = 73 and n = 59, respectively). As exploratory analyses, correlation analyses were performed between indices of the Wechsler Memory Scale‐Revised and regional brain volume where the volume were significantly smaller. As a reference, MRI scans of cancer survivors were compared with those of healthy controls (n = 55 for the 1‐year study and n = 37 for the 3‐year study). RESULTS.: The C+ patients had smaller gray matter and white matter including prefrontal, parahippocampal, and cingulate gyrus, and precuneus in the 1‐year study. However, no difference was observed in the 3‐year study. The volumes of the prefrontal, parahippocampal gyrus, and precuneus were significantly correlated with indices of attention/concentration and/or visual memory. Comparisons with healthy controls did not show any significant differences. CONCLUSIONS.: Adjuvant chemotherapy might have an influence on brain structure, which may account for previously observed cognitive impairments. Cancer 2007. © 2006 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
The precuneus: a review of its functional anatomy and behavioural correlates
Cavanna, A. E., & Trimble, M. R. (2006) · Brain · doi:10.1093/brain/awl004 · Cited by 5,128
A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains
Good, C. D., Johnsrude, I. S., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0786 · Cited by 4,561
Reynolds, C. R., & Powel, J. (1988) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/3.4.397 · Cited by 2,095
Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Nonlinear spatial normalization using basis functions
Ashburner, J., & Friston, K. J. (1999) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(1999)7:4<254::aid-hbm4>3.0.co;2-g · Cited by 1,884
Good, C. D., Johnsrude, I., Ashburner, J., Henson, R. N. A., Friston, K. J., & Frackowiak, R. S. J. (2001) · NeuroImage · doi:10.1006/nimg.2001.0857 · Cited by 1,213
Detecting activations in PET and fMRI: levels of inference and power
Friston, K. J., Holmes, A., Poline, J.-B., Price, C. J., & Frith, C. D. (1996) · NeuroImage · doi:10.1006/nimg.1996.0074 · Cited by 1,148 · cited 1×
“05, after family-wise error correction for multiple comparisons.(33) In all analyses, we reported the Montreal Neurological Institute (MNI) coordinates of voxels of statistical significance.”
MethodThe problem of functional localization in the human brain
Brett, M., Johnsrude, I. S., & Owen, A. M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn756 · Cited by 1,119
The problem of functional localization in the human brain
Morgan, T. (2002) · Cited by 965
Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.485 · Cited by 736
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Incorporating Prior Knowledge into Image Registration
Ashburner, J., Neelin, P., Collins, D. L., Evans, A., & Friston, K. (1997) · NeuroImage · doi:10.1006/nimg.1997.0299 · Cited by 460
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K.-A. (2005) · Brain and Cognition · doi:10.1016/j.bandc.2005.05.001 · Cited by 315
ANDERSON-HANLEY, C., SHERMAN, M. L., RIGGS, R., AGOCHA, V. B., & COMPAS, B. E. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703970019 · Cited by 302
Fan, H. G. M., Houédé-Tchen, N., Yi, Q.-L., Chemerynsky, I., Downie, F. P., Sabate, K., & Tannock, I. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.6550 · Cited by 280
Schagen, S. B., Muller, M. J., Boogerd, W., Rosenbrand, R. M., van Rhijn, D., Rodenhuis, S., & van Dam, F. S. A. M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf241 · Cited by 262
Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005) · Cancer · doi:10.1002/cncr.21469 · Cited by 242
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/s1084-3612(03)00055-8 · Cited by 194
Joshi, G., Sultana, R., Tangpong, J., Cole, M. P., St Clair, D. K., Vore, M., Estus, S., & Butterfield, D. A. (2005) · Free Radical Research · doi:10.1080/10715760500143478 · Cited by 184
Neurotoxicity secondary to antineoplastic drugs
Tuxen, M. K., & Hansen, S. W. (1994) · Cancer Treatment Reviews · doi:10.1016/0305-7372(94)90027-2 · Cited by 167
Usefulness of a Japanese version of the Mini-Mental State Test in neurological patients
Mori (1985) · Cited by 155
Anticancer agents are potent neurotoxins in vitro and in vivo
Rzeski, W., Pruskil, S., Macke, A., Felderhoff‐Mueser, U., Reiher, A. K., Hoerster, F., Jansma, C., Jarosz, B., Stefovska, V. G., Bittigau, P., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20185 · Cited by 134
Adjuvant Breast Cancer Treatment and Cognitive Function: Current Knowledge and Research Directions
Phillips, K., & Bernhard, J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.190 · Cited by 133
The Parahippocampal RegionOrganization and Role in Cognitive Function
Witter, M. P., & Wouterlood, F. G. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198509172.001.0001 · Cited by 111
Hippocampal brain amines in methotrexate-induced learning and memory deficit
Madhyastha, S., Somayaji, S. N., Rao, M. S. R., Nalini, K., & Bairy, L. K. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-135 · Cited by 102
Matsuda, T., Takayama, T., Tashiro, M., Nakamura, Y., Ohashi, Y., & Shimozuma, K. (2005) · Breast Cancer · doi:10.2325/jbcs.12.279 · Cited by 101
Mild cognitive impairment: Conceptual issues and structural and functional brain correlates
Saykin, A. J., & Wishart, H. A. (2003) · Seminars in Clinical Neuropsychiatry · doi:10.1053/scnp.2003.50002 · Cited by 95
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer
Choi, S. M., Lee, S., Yang, Y. S., Kim, B. C., Kim, M. K., & Cho, K. H. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.3.328 · Cited by 76
Rugo, H. S., & Ahles, T. A. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.09.008 · Cited by 68
No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors
Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., Fujimori, M., Nakaya, N., Akizuki, N., Imoto, S., et al. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-1412-6 · Cited by 66
Self-citationA pilot study of Interpersonal Psychotherapy by telephone with cancer patients and their partners
Donnelly, J. M., Kornblith, A. B., Fleishman, S., Zuckerman, E., Raptis, G., Hudis, C. A., Hamilton, N., Payne, D., Massie, M. J., Norton, L., et al. (2000) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(200001/02)9:1 · Cited by 65
Mapping Prefrontal Cortical Systems for the Control of Cognition
Petrides, M. (2000) · Elsevier eBooks · doi:10.1016/b978-012692545-6/50008-8 · Cited by 65
Omura, K., & Sugishita, M. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390409609788 · Cited by 11
Worsley (1996) · doi:10.1002/(sici)1097-0193(1996)4:1
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0189 · Cited by 556
Wefel, J. S., Kesler, S. R., Noll, K. R., & Schagen, S. B. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21258 · Cited by 532
Metadata
- Authors
- Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., Wada, N., Imoto, S., Murakami, K., Uchitomi, Y., & and The Breast Cancer Survivors' Brain MRI Database Group
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2006-12-11
- Volume
- 109
- Issue
- 1
- Pages
- 146-156
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2049116727
- Cited by
- 350
- References
- 37
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.